TEST DOSE FOR PREDICTING HIGH-DOSE METHOTREXATE INFUSIONS

被引：49

作者：

KERR, IG

JOLIVET, J

COLLINS, JM

DRAKE, JC

CHABNER, BA

机构：

[1] NCI,DIV CANC TREATMENT,CLIN PHARMACOL BRANCH,BETHESDA,MD 20205

[2] NIH,DIV RES SERV,BIOMED ENGN & INSTRUMENTAT BRANCH,BETHESDA,MD 20205

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1983年 / 33卷 / 01期

关键词：

D O I：

10.1038/clpt.1983.6

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：44 / 51

页数：8

共 21 条

[1] USE OF SERUM CREATININE CONCENTRATIONS TO DETERMINE RENAL-FUNCTION [J].

BJORNSSON, TD .

CLINICAL PHARMACOKINETICS, 1979, 4 (03) :200-222

[2]

CHAN H, 1977, CANCER TREAT REP, V61, P797

[3]

EVANS WE, 1979, CANCER CHEMOTH PHARM, V3, P161

[4]

EVANS WE, 1982, P AM ASS CLIN ONCOL, V1, P11

[5]

EVANS WE, 1980, APPLIED PHARMACOKINE

[6] HIGH-DOSE METHOTREXATE WITH LEUCOVORIN RESCUE - RATIONALE AND SPECTRUM OF ANTI-TUMOR ACTIVITY [J].

FREI, E ;

BLUM, RH ;

PITMAN, SW ;

KIRKWOOD, JM ;

HENDERSON, IC ;

SKARIN, AT ;

MAYER, RJ ;

BAST, RC ;

GARNICK, MB ;

PARKER, LM ;

CANELLOS, GP .

AMERICAN JOURNAL OF MEDICINE, 1980, 68 (03) :370-376

[7]

GIBALDI M, 1975, PHARMACOKINETICS, P69

[8] VARIABILITY OF INDIVIDUAL TOLERANCE TO METHOTREXATE IN CANCER PATIENTS [J].

HANSEN, HH ;

SELAWRY, OS ;

HOLLAND, JF ;

MCCALL, CB .

BRITISH JOURNAL OF CANCER, 1971, 25 (02) :298-&

[9]

ISACOFF WH, 1977, CANCER TREAT REP, V61, P1665

[10] MLAB - MATHEMATICAL-MODELING TOOL [J].

KNOTT, GD .

COMPUTER PROGRAMS IN BIOMEDICINE, 1979, 10 (03) :271-280

← 1 2 3 →